Wanda Toro Turini, Pharm.D., President, Bull’s Eye Innovations (BEI)
Dr Wanda Toro Turini is the Chief Executive Officer of Bull’s Eye Innovations and serves as the Lead Advisor for BEI’s Disclosure & Transparency Services. With over 15 years of healthcare industry experience as a critical care pharmacist and pharmaceutical sales, marketing and eBusiness executive, her varied background provides BEI clients with an unparalleled perspective on Disclosure & Transparency. Having set her sights on Aggregate Spend as a problem space in 2006, Dr. Turini has led the development of the Aggregate Spend RoadMap® (ASR) methodology, which BEI uses to leverage her expertise across all clients. Dr. Turini and the BEI Disclosure & Transparency team hold a deep understanding of the commercial, clinical and executive level issues that challenge a company’s aggregate spend objectives. Dr. Turini often serves as the Lead Subject Matter Expert for BEI aggregate spend advisory engagements, has advised in the development and refinement of various commercialized aggregate spend software solutions, is the lead trainer and coach for the BEI Disclosure & Transparency team and is a frequent lecturer at industry conferences which focus on aggregate spend and the Federal Sunshine Act. Dr. Turini has moderated Aggregate Spend Alliance discussions related to the day to day tactical challenges of managing an aggregate spend program and has facilitated productive and entertaining discussions amongst hundreds of life science executives.
Bull’s Eye Innovations is excited to announce the launch of The ASA University, the first on-line virtual learning environment and networking community for aggregate spend professionals. Designed to serve those professionals responsible for developing manufacturer programs to comply with state level and federal Sunshine Act requirements, The ASA University includes a networking Student Lounge, a Main Lecture […]